Loading...

Sree Rayalaseema Hi-Strength Hypo

NSEI:SRHHYPOLTD
Snowflake Description

Excellent balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SRHHYPOLTD
NSEI
₹2B
Market Cap
  1. Home
  2. IN
  3. Materials
Company description

Sree Rayalaseema Hi-Strength Hypo Limited manufactures and sells inorganic chemicals in India. The last earnings update was 47 days ago. More info.


Add to Portfolio Compare Print
  • Sree Rayalaseema Hi-Strength Hypo has significant price volatility in the past 3 months.
SRHHYPOLTD Share Price and Events
7 Day Returns
-5.5%
NSEI:SRHHYPOLTD
-1%
IN Chemicals
-0.5%
IN Market
1 Year Returns
-16.2%
NSEI:SRHHYPOLTD
1.4%
IN Chemicals
-1.8%
IN Market
SRHHYPOLTD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) -5.5% -17.5% -40% -16.2% 12.8% 298%
IN Chemicals -1% -4.9% -6.5% 1.4% 38.6% 123.1%
IN Market -0.5% -2.7% -4.7% -1.8% 22.9% 34.2%
1 Year Return vs Industry and Market
  • SRHHYPOLTD underperformed the Chemicals industry which returned 1.4% over the past year.
  • SRHHYPOLTD underperformed the Market in India which returned -1.8% over the past year.
Price Volatility
SRHHYPOLTD
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Sree Rayalaseema Hi-Strength Hypo undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Sree Rayalaseema Hi-Strength Hypo. This is due to cash flow or dividend data being unavailable. The share price is ₹107.45.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Sree Rayalaseema Hi-Strength Hypo's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Sree Rayalaseema Hi-Strength Hypo's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NSEI:SRHHYPOLTD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in INR ₹11.90
BSE:532842 Share Price ** BSE (2019-07-16) in INR ₹106.2
India Chemicals Industry PE Ratio Median Figure of 233 Publicly-Listed Chemicals Companies 12.52x
India Market PE Ratio Median Figure of 2,834 Publicly-Listed Companies 14.78x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Sree Rayalaseema Hi-Strength Hypo.

NSEI:SRHHYPOLTD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:532842 Share Price ÷ EPS (both in INR)

= 106.2 ÷ 11.90

8.92x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sree Rayalaseema Hi-Strength Hypo is good value based on earnings compared to the IN Chemicals industry average.
  • Sree Rayalaseema Hi-Strength Hypo is good value based on earnings compared to the India market.
Price based on expected Growth
Does Sree Rayalaseema Hi-Strength Hypo's expected growth come at a high price?
Raw Data
NSEI:SRHHYPOLTD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 8.92x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
18.1%per year
India Chemicals Industry PEG Ratio Median Figure of 50 Publicly-Listed Chemicals Companies 1.29x
India Market PEG Ratio Median Figure of 536 Publicly-Listed Companies 1.29x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Sree Rayalaseema Hi-Strength Hypo, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Sree Rayalaseema Hi-Strength Hypo's assets?
Raw Data
NSEI:SRHHYPOLTD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in INR ₹189.65
BSE:532842 Share Price * BSE (2019-07-16) in INR ₹106.2
India Chemicals Industry PB Ratio Median Figure of 271 Publicly-Listed Chemicals Companies 1.25x
India Market PB Ratio Median Figure of 3,668 Publicly-Listed Companies 0.95x
NSEI:SRHHYPOLTD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:532842 Share Price ÷ Book Value per Share (both in INR)

= 106.2 ÷ 189.65

0.56x

* Primary Listing of Sree Rayalaseema Hi-Strength Hypo.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sree Rayalaseema Hi-Strength Hypo is good value based on assets compared to the IN Chemicals industry average.
X
Value checks
We assess Sree Rayalaseema Hi-Strength Hypo's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Sree Rayalaseema Hi-Strength Hypo has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Sree Rayalaseema Hi-Strength Hypo expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Sree Rayalaseema Hi-Strength Hypo, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
18.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Sree Rayalaseema Hi-Strength Hypo expected to grow at an attractive rate?
  • Sree Rayalaseema Hi-Strength Hypo's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Sree Rayalaseema Hi-Strength Hypo's earnings growth is expected to exceed the India market average.
  • Unable to compare Sree Rayalaseema Hi-Strength Hypo's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NSEI:SRHHYPOLTD Future Growth Rates Data Sources
Data Point Source Value (per year)
NSEI:SRHHYPOLTD Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 18.1%
India Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 16.7%
India Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 13.2%
India Market Earnings Growth Rate Market Cap Weighted Average 17%
India Market Revenue Growth Rate Market Cap Weighted Average 9.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NSEI:SRHHYPOLTD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NSEI:SRHHYPOLTD Future Estimates Data
Date (Data in INR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
NSEI:SRHHYPOLTD Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2019-03-31 7,021 204
2018-12-31 6,820 528
2018-09-30 6,518 441
2018-06-30 5,994 376
2018-03-31 5,511 51 366
2017-12-31 2,639 97
2017-09-30 2,109 104
2017-06-30 1,887 107
2017-03-31 1,643 -76 87
2016-12-31 3,797 196
2016-09-30 3,941 248
2016-06-30 3,688 236

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Sree Rayalaseema Hi-Strength Hypo's earnings are expected to grow by 18.1% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Sree Rayalaseema Hi-Strength Hypo is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NSEI:SRHHYPOLTD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Sree Rayalaseema Hi-Strength Hypo Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:SRHHYPOLTD Future Estimates Data
Date (Data in INR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
NSEI:SRHHYPOLTD Past Financials Data
Date (Data in INR Millions) EPS *
2019-03-31 11.90
2018-12-31 30.10
2018-09-30 25.74
2018-06-30 22.75
2018-03-31 22.45
2017-12-31 6.33
2017-09-30 6.92
2017-06-30 7.20
2017-03-31 5.93
2016-12-31 13.35
2016-09-30 16.83
2016-06-30 16.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Sree Rayalaseema Hi-Strength Hypo will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Sree Rayalaseema Hi-Strength Hypo's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Sree Rayalaseema Hi-Strength Hypo has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Sree Rayalaseema Hi-Strength Hypo performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Sree Rayalaseema Hi-Strength Hypo's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Sree Rayalaseema Hi-Strength Hypo has delivered over 20% year on year earnings growth in the past 5 years.
  • Sree Rayalaseema Hi-Strength Hypo's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Sree Rayalaseema Hi-Strength Hypo's 1-year earnings growth is negative, it can't be compared to the IN Chemicals industry average.
Earnings and Revenue History
Sree Rayalaseema Hi-Strength Hypo's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Sree Rayalaseema Hi-Strength Hypo Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:SRHHYPOLTD Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 7,021.40 204.26 214.76
2018-12-31 6,820.11 528.46 247.52
2018-09-30 6,518.28 441.30 234.63
2018-06-30 5,994.50 375.54 227.51
2018-03-31 5,510.55 366.06 212.95
2017-12-31 2,639.47 96.87 51.32
2017-09-30 2,109.06 104.38 54.46
2017-06-30 1,886.65 107.34 55.56
2017-03-31 1,642.88 87.34 54.43
2016-12-31 3,796.58 196.39 155.95
2016-09-30 3,941.50 247.79 147.22
2016-06-30 3,687.63 235.62 136.83
2016-03-31 3,634.62 250.50 137.83
2015-12-31 3,586.58 209.88 689.01
2015-09-30 3,650.19 172.10 688.12
2015-06-30 2,260.50 193.33 45.13
2015-03-31 3,923.73 193.71 681.23
2014-12-31 3,850.26 155.37 539.28
2014-09-30 3,584.74 143.55 531.99
2014-06-30 4,870.56 110.72 194.78
2014-03-31 2,967.01 74.36 519.93
2013-12-31 2,899.83 25.15 539.19
2013-09-30 2,954.17 27.35 530.80
2013-06-30 2,979.21 68.87 541.29
2013-03-31 3,017.10 92.91 533.25
2012-12-31 2,900.50 97.41 112.59
2012-09-30 2,565.51 152.36 94.14

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Sree Rayalaseema Hi-Strength Hypo has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Sree Rayalaseema Hi-Strength Hypo used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
  • Sree Rayalaseema Hi-Strength Hypo has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Sree Rayalaseema Hi-Strength Hypo's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Sree Rayalaseema Hi-Strength Hypo has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Sree Rayalaseema Hi-Strength Hypo's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Sree Rayalaseema Hi-Strength Hypo's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Sree Rayalaseema Hi-Strength Hypo is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Sree Rayalaseema Hi-Strength Hypo's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Sree Rayalaseema Hi-Strength Hypo's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 4.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Sree Rayalaseema Hi-Strength Hypo Company Filings, last reported 3 months ago.

NSEI:SRHHYPOLTD Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 3,253.15 455.36 151.86
2018-12-31 3,195.57 416.43 227.09
2018-09-30 3,195.57 416.43 227.09
2018-06-30
2018-03-31 3,179.87 781.20 29.79
2017-12-31
2017-09-30
2017-06-30 1,965.03 792.07 75.90
2017-03-31 1,965.03 792.07 75.90
2016-12-31 1,974.55 586.62 98.80
2016-09-30 1,974.55 586.62 98.80
2016-06-30 2,034.91 950.62 57.99
2016-03-31 2,034.91 850.87 57.99
2015-12-31 1,917.55 927.40 64.50
2015-09-30 1,917.55 927.40 64.50
2015-06-30 1,717.10 664.51 61.12
2015-03-31 1,717.10 874.19 61.12
2014-12-31 1,602.10 789.22 57.24
2014-09-30 1,602.10 789.22 57.24
2014-06-30 1,492.95 877.98 73.33
2014-03-31 1,492.95 1,041.56 83.33
2013-12-31
2013-09-30
2013-06-30 1,398.42 1,166.52 88.42
2013-03-31 1,398.42 1,166.52 88.42
2012-12-31 1,389.54 1,076.06 31.62
2012-09-30 1,389.54 1,076.06 31.62
  • Sree Rayalaseema Hi-Strength Hypo's level of debt (14%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (69.6% vs 14% today).
  • Debt is not well covered by operating cash flow (11.2%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 4.6x coverage).
X
Financial health checks
We assess Sree Rayalaseema Hi-Strength Hypo's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Sree Rayalaseema Hi-Strength Hypo has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Sree Rayalaseema Hi-Strength Hypo's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.88%
Current annual income from Sree Rayalaseema Hi-Strength Hypo dividends.
If you bought ₹2,000 of Sree Rayalaseema Hi-Strength Hypo shares you are expected to receive ₹38 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Sree Rayalaseema Hi-Strength Hypo's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.56%).
  • Sree Rayalaseema Hi-Strength Hypo's dividend is below the markets top 25% of dividend payers in India (2.18%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NSEI:SRHHYPOLTD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
India Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 171 Stocks 1%
India Market Average Dividend Yield Market Cap Weighted Average of 1447 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.6%
India Top 25% Dividend Yield 75th Percentile 2.2%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NSEI:SRHHYPOLTD Future Dividends Estimate Data
Date (Data in ₹) Dividend per Share (annual) Avg. No. Analysts
NSEI:SRHHYPOLTD Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2019-05-30 2.000 1.571
2018-09-12 2.000 1.278
2017-09-01 1.500 0.899
2017-05-30 1.500 1.169
2016-10-03 1.500 1.130
2016-05-30 1.500 1.505
2015-09-10 1.500 2.387
2015-07-06 1.500 2.231
2015-05-29 1.500 2.870
2013-02-14 0.000 0.000
2012-11-15 0.000 0.000
2012-08-16 0.000 0.000
2011-08-29 1.500 3.406
2011-06-01 1.500 3.589

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sree Rayalaseema Hi-Strength Hypo has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but Sree Rayalaseema Hi-Strength Hypo only paid a dividend in the past 8 years.
Current Payout to shareholders
What portion of Sree Rayalaseema Hi-Strength Hypo's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (6x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Sree Rayalaseema Hi-Strength Hypo's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Sree Rayalaseema Hi-Strength Hypo afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Sree Rayalaseema Hi-Strength Hypo has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Sree Rayalaseema Hi-Strength Hypo's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Tumbalam Bharath
COMPENSATION ₹24,000,000
AGE 43
TENURE AS CEO 0.2 years
CEO Bio

Mr. Tumbalam Gooty Bharath, B.Com., MBA (UK) serves as the Chairman of Sree Rayalaseema Hi-Strength Hypo Limited and TGV Projects and Investments Pvt. Ltd. Mr. Bharath served as Managing Director of SRHHL Industries Limited from January 2005 to August 24, 2011. He serves as the Managing Director of Sree Rayalaseema Hi-Strength Hypo Limited since May 30, 2019. He served as Chief Executive Officer and Managing Director of Sree Rayalaseema Hi-Strength Hypo Limited until March 20, 2019. He served as Managing Director of Sree Rayalaseema Alkalies & Allied Chemicals Ltd. He serves as the Chairman of TGV Pharma Private Limited. He served as Chairman of Sree Rayalaseema Alkalies & Allied Chemicals Ltd. He served as the Chairman and Director of Stampede Capital Ltd until August 14, 2008 and SRHHL Industries Limited until August 24, 2011. He serves as a Director of Andhra Pradesh Gas Power Corporation Ltd. He has been a Director of Sree Rayalaseema Hi-Strength Hypo Limited since July 26, 2005. He served as a Director of SRHHL Industries Limited from July 25, 2006 to August 24, 2011 and Sree Maruthi Marine Industries Ltd, until July 30, 2009. He served as a Director of Sree Rayalaseema Alkalies & Allied Chemicals Ltd. Mr. Bharath received a post graduate degree in Business Administration from Cardiff University.

CEO Compensation
  • Tumbalam's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
  • Tumbalam's remuneration is higher than average for companies of similar size in India.
Management Team

Tumbalam Bharath

TITLE
Chairman & MD
COMPENSATION
₹24M
AGE
43
TENURE
0.2 yrs

Shaik Ahmed

TITLE
CFO & GM of Finance and Accounting
COMPENSATION
₹691K
TENURE
3.8 yrs

Vobugari Surekha

TITLE
GM, Compliance Officer & Company Secretary
COMPENSATION
₹663K
AGE
49
Board of Directors Tenure

Average tenure and age of the Sree Rayalaseema Hi-Strength Hypo board of directors in years:

4.9
Average Tenure
55
Average Age
  • The tenure for the Sree Rayalaseema Hi-Strength Hypo board of directors is about average.
Board of Directors

Tumbalam Bharath

TITLE
Chairman & MD
COMPENSATION
₹24M
AGE
43

Agadi Kailashnath

TITLE
Independent Director
COMPENSATION
₹41K
AGE
36
TENURE
3.2 yrs

Duggi Leela

TITLE
Independent Director
COMPENSATION
₹41K
AGE
55
TENURE
4.9 yrs

Krishnamoorthy Naik

TITLE
Non-Executive Director
COMPENSATION
₹20K
AGE
85
TENURE
4.9 yrs

P. Gowd

TITLE
Independent Director
COMPENSATION
₹41K
AGE
66
TENURE
4.9 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
X
Management checks
We assess Sree Rayalaseema Hi-Strength Hypo's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Sree Rayalaseema Hi-Strength Hypo has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) Struggling With Its 14% Return On Capital Employed?

Analysts use this formula to calculate return on capital employed: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Sree Rayalaseema Hi-Strength Hypo: 0.14 = ₹480m ÷ (₹4.7b - ₹1.2b) (Based on the trailing twelve months to March 2019.) So, Sree Rayalaseema Hi-Strength Hypo has an ROCE of 14%. … What Are Current Liabilities, And How Do They Affect Sree Rayalaseema Hi-Strength Hypo's ROCE? … What We Can Learn From Sree Rayalaseema Hi-Strength Hypo's ROCE If Sree Rayalaseema Hi-Strength Hypo continues to earn an uninspiring ROCE, there may be better places to invest.

Simply Wall St -

How Much Of Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) Do Insiders Own?

As Charlie Munger said 'Show me the incentive and I will show you the outcome.' With a market capitalization of ₹2.8b, Sree Rayalaseema Hi-Strength Hypo is a small cap stock, so it might not be well known by many institutional investors. … Check out our latest analysis for Sree Rayalaseema Hi-Strength Hypo NSEI:SRHHYPOLTD Ownership Summary, May 29th 2019 What Does The Lack Of Institutional Ownership Tell Us About Sree Rayalaseema Hi-Strength Hypo? … Insider Ownership Of Sree Rayalaseema Hi-Strength Hypo While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders.

Simply Wall St -

Do You Like Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) At This P/E Ratio?

We'll show how you can use Sree Rayalaseema Hi-Strength Hypo Limited's (NSE:SRHHYPOLTD) P/E ratio to inform your assessment of the investment opportunity. … Sree Rayalaseema Hi-Strength Hypo has a price to earnings ratio of 5.18, based on the last twelve months. … The formula for price to earnings is: Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS) Or for Sree Rayalaseema Hi-Strength Hypo: P/E of 5.18 = ₹156.05 ÷ ₹30.1 (Based on the trailing twelve months to December 2018.) Is A High Price-to-Earnings Ratio Good?

Simply Wall St -

Does Sree Rayalaseema Hi-Strength Hypo (NSE:SRHHYPOLTD) Deserve A Spot On Your Watchlist?

In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like Sree Rayalaseema Hi-Strength Hypo (NSE:SRHHYPOLTD). … Check out our latest analysis for Sree Rayalaseema Hi-Strength Hypo? … Sree Rayalaseema Hi-Strength Hypo shareholders can take confidence from the fact that EBIT margins are up from 4.7% to 6.7%, and revenue is growing.

Simply Wall St -

Why Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) Is An Attractive Investment To Consider

As an investor, I look for investments which does not compromise one fundamental factor for another. … By this I mean, I look at stocks holistically, from their financial health to their future outlook. … is a company with great financial health as well as a.

Simply Wall St -

Should You Be Excited About Sree Rayalaseema Hi-Strength Hypo Limited's (NSE:SRHHYPOLTD) 17% Return On Equity?

To keep the lesson grounded in practicality, we'll use ROE to better understand Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD). … Sree Rayalaseema Hi-Strength Hypo has a ROE of 17%, based on the last twelve months. … Check out our latest analysis for Sree Rayalaseema Hi-Strength Hypo?

Simply Wall St -

How Should Investors React To Sree Rayalaseema Hi-Strength Hypo Limited's (NSE:SRHHYPOLTD) CEO Pay?

The CEO of Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) is Tumbalam Bharath. … This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … According to our data, Sree Rayalaseema Hi-Strength Hypo Limited has a market capitalization of ₹2.9b, and pays its CEO total annual compensation worth ₹24m.

Simply Wall St -

Does Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) Have A Place In Your Dividend Stock Portfolio?

Historically, Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) has been paying a dividend to shareholders. … Does Sree Rayalaseema Hi-Strength Hypo tick all the boxes of a great dividend stock? … Check out our latest analysis for Sree Rayalaseema Hi-Strength Hypo

Simply Wall St -

Should Sree Rayalaseema Hi-Strength Hypo Limited’s (NSE:SRHHYPOLTD) Weak Investment Returns Worry You?

Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … What is Return On Capital Employed (ROCE)? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.

Simply Wall St -

Did Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD) Insiders Buy Up More Shares?

So before you buy or sell Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD), you may well want to know whether insiders have been buying or selling. … The Last 12 Months Of Insider Transactions At Sree Rayalaseema Hi-Strength Hypo … The insider buying may not tell us much about how insiders feel about the current share price.

Simply Wall St -

Company Info

Description

Sree Rayalaseema Hi-Strength Hypo Limited manufactures and sells inorganic chemicals in India. The company operates in two segments, Chemical Manufacturing and Power generation. It offers sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids, as well as chloramine, purichlor, oleum, sodium dichloroisocyanurate, hydrogen gas, aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder, sodium methoxide solution, and water treatment chemicals. The company also generates power through thermal, solar, and wind mills. It also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.

Details
Name: Sree Rayalaseema Hi-Strength Hypo Limited
SRHHYPOLTD
Exchange: NSEI
Founded: 2005
₹1,802,306,205
17,164,821
Website: http://www.srhhl.com
Address: Sree Rayalaseema Hi-Strength Hypo Limited
216, K.J.S.Complex,
Bhagya Nagar,
Kurnool,
Andhra Pradesh, 518004,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 532842 Equity Shares Mumbai Stock Exchange IN INR 08. May 2007
NSEI SRHHYPOLTD Equity Shares National Stock Exchange of India IN INR 08. May 2007
Number of employees
Current staff
Staff numbers
400
Sree Rayalaseema Hi-Strength Hypo employees.
Industry
Commodity Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/16 12:52
End of day share price update: 2019/07/16 00:00
Last estimates confirmation: 2018/05/30
Last earnings filing: 2019/05/30
Last earnings reported: 2019/03/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.